Rednex Pharmaceutica
Ticker > Company >

Rednex Pharmaceutica share price

Rednex Pharmaceuticals Ltd.

 217   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year87.67%
3 YearNA
5 YearNA

Profit Growth

1 Year120.44%
3 YearNA
5 YearNA

ROE%

1 Year58.1%
3 Year25.15%

ROCE %

1 Year25.44%
3 Year13.43%

Debt/Equity

2.021

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 25.1486666666667% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 1.7 24.41 45.8
Total Expenditure 2.01 19.77 36.5
Operating Profit -0.31 4.63 9.3
Other Income 0.02 0.08 0.32
Interest 0.59 1.2 1.59
Depreciation 0.22 1.17 2.87
Exceptional Items 0 0 0
Profit Before Tax -1.1 2.34 5.16
Tax -0.18 0.41 0.89
Net Profit -0.93 1.93 4.26
Adjusted EPS (Rs.) -1.21 2.53 5.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.25 4.25 4.25
Total Reserves -0.98 0.96 5.22
Borrowings 4.9 9.56 9.29
Other N/C liabilities -0.17 0.14 0.1
Current liabilities 8.93 17.85 31.26
Total Liabilities 16.93 32.75 50.12
Assets
Net Block 4.31 16.38 16.04
Capital WIP 6.12 0 0
Intangible WIP 0 0 0
Investments 0 0 0
Loans & Advances 0.09 0.3 0.08
Other N/C Assets 0.06 0.17 0
Current Assets 6.35 15.9 33.99
Total Assets 16.93 32.75 50.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 2.34 5.16
Adjustment 2.3 4.19
Changes in Assets & Liabilities -3.78 -7.46
Tax Paid 0.03 0.64
Operating Cash Flow 0.89 2.53
Investing Cash Flow -7.42 -2.19
Financing Cash Flow 7.73 -1.34
Net Cash Flow 1.2 -1

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Rednex Pharmaceutica
X